Vitamin D Supplementation Prevents Elderly Pneumonia
|ClinicalTrials.gov Identifier: NCT00877422|
Recruitment Status : Completed
First Posted : April 7, 2009
Last Update Posted : April 8, 2009
|Condition or disease||Intervention/treatment|
|Bacterial Pneumonia||Dietary Supplement: Vitamin D3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||100 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Vitamin D Supplementation Prevents Pneumonia in Institutionalized Elderly Subjects|
|Study Start Date :||August 2008|
No Intervention: Group A
Group A is identified as serum vitamin D level more than 16 ng/dl.
Active Comparator: Group B
Group B is identified as serum vitamin D level less than 16 ng/dl and is supplemented with vitamin D3.
Dietary Supplement: Vitamin D3
Group A and Group C are followed without drugs and Group B is followed with vitamin D3.
No Intervention: Group C
Group C is identified as serum vitamin D less than 16 ng/dl and is not supplemented with vitamin D3.
- prevalence of pneumonia [ Time Frame: one year ]
- all cause mortality [ Time Frame: one year ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00877422
|Institute of Development, Aging and Cancer, Tohoku University|
|1-1,Seiryo-machi,Aoba-ku,Sendai, Japan, 980-8575|
|Study Chair:||Hiroyuki Arai, MD||Department of Geriatrics and Gerontology, Tohoku University|